Heyholder
‹ Activism Filings

GENOLUTION INC. Q3 revenue KRW 2.6 billion, operating loss KRW 2.0 billion

GENOLUTION INC.· Periodic Report

AI summary · Not investment advice

Genolution sold KRW 2.6 billion in Q3 but lost KRW 2.0 billion from its main business; sales rose 23.3% from a year earlier and fell 17.5% from the prior quarter.

Operating profit · 3 months

KRW -2.0 billion

Key facts

Revenue (3 months)
KRW 2.6 billion
Net income (3 months)
KRW -4.8 billion
Period
Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
Revenue (prior-year 3 months)
KRW 2.1 billion
Revenue (year to date)
KRW 8.1 billion
Operating profit (prior-year 3 months)
KRW -2.4 billion
Operating profit (year to date)
KRW -4.9 billion
Net income (prior-year 3 months)
KRW -1.3 billion
Net income (year to date)
KRW -3.9 billion

Commentary

AI commentary · Not investment advice

What happened

Genolution filed its quarterly report for Q3 2026 on a consolidated basis. Sales for the 3 months were KRW 2.55 billion. That compares with KRW 2.07 billion a year earlier. Sales rose 23.3% from a year earlier and fell 17.5% from the previous quarter.

In the company's terms

Operating profit, the money earned from the core business, was a loss of KRW 1.97 billion for the 3 months. A year earlier, the loss was KRW 2.44 billion.

What changes for shareholders

Net income, the final profit after everything, was a loss of KRW 4.85 billion for the 3 months. A year earlier, the loss was KRW 1.26 billion. The company moved from a profit in the previous quarter to a loss this quarter.

For the year to date (Jan 1 to Sep 30), sales were KRW 8.13 billion. Operating profit was a loss of KRW 4.95 billion. Net income was a loss of KRW 3.90 billion.

Comments

No comments yet

Comments from shareholders will appear here.